Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasion
Hongjie Sun, Dongli Huang, Guozheng Liu, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 3959-3968
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng, He Cai, Manni Wang, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 883
The sirtuin family in health and disease
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 388
The Roles of Mitochondrial SIRT4 in Cellular Metabolism
Zheying Min, Jiangman Gao, Yang Yu
Frontiers in Endocrinology (2019) Vol. 9
Open Access | Times Cited: 119
The Roles of Sirtuin Family Proteins in Cancer Progression
Erhu Zhao, Jianbing Hou, Xiaoxue Ke, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1949-1949
Open Access | Times Cited: 103
Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators
Ewa Maria Kratz, Katarzyna Sołkiewicz, Adriana Kubis-Kubiak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 630-630
Open Access | Times Cited: 62
Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
Aranka Brockmueller, Saba Sameri, Alena Líšková, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 188-188
Open Access | Times Cited: 60
The emerging roles of HDACs and their therapeutic implications in cancer
Rihan Hai, Deyi Yang, Feifei Zheng, et al.
European Journal of Pharmacology (2022) Vol. 931, pp. 175216-175216
Closed Access | Times Cited: 48
Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin
Han Li, Lijun Jia, Fei Wu, et al.
Molecular Cancer Research (2019) Vol. 17, Iss. 11, pp. 2267-2280
Open Access | Times Cited: 71
CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions
Abu Hazafa, Muhammad Mumtaz, Muhammad Farooq, et al.
Life Sciences (2020) Vol. 263, pp. 118525-118525
Open Access | Times Cited: 68
Shedding light on structure, function and regulation of human sirtuins: a comprehensive review
Abhishek Sharma, Pragati Mahur, Jayaraman Muthukumaran, et al.
3 Biotech (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages
Zhi Li, He Li, Zhibo Zhao, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 53
The sirtuin family in cancer
Luis Filipe Costa‐Machado, Pablo J. Fernández-Marcos
Cell Cycle (2019) Vol. 18, Iss. 18, pp. 2164-2196
Open Access | Times Cited: 47
Applications of CRISPR/Cas9 Technology in the Treatment of Lung Cancer
Chunyang Jiang, Xiaohui Lin, Zhigang Zhao
Trends in Molecular Medicine (2019) Vol. 25, Iss. 11, pp. 1039-1049
Closed Access | Times Cited: 47
Inhibition of SIRT4 promotes bladder cancer progression and immune escape via attenuating CD8+ T cells function
Jiancheng Lv, Yu Zhang, Qiang Lü, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113906-113906
Closed Access
Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development
Z. J. Ke, Kaikai Shen, Li Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
SIRT4 enhances the sensitivity of ER‐positive breast cancer to tamoxifen by inhibiting the IL‐6/STAT3 signal pathway
Jilin Xing, Ji Li, Lin Fu, et al.
Cancer Medicine (2019) Vol. 8, Iss. 16, pp. 7086-7097
Open Access | Times Cited: 34
Sustained Exposure to Helicobacter pylori Lysate Inhibits Apoptosis and Autophagy of Gastric Epithelial Cells
Yang He, Cunlong Wang, Xiulin Zhang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 30
Mitochondrial sirtuins in stem cells and cancer
Amit Jaiswal, Xudong Zhu, Zhenyu Ju, et al.
FEBS Journal (2021) Vol. 289, Iss. 12, pp. 3393-3415
Open Access | Times Cited: 26
SIRT5 downregulation is associated with poor prognosis in glioblastoma
Xi Chen, Zhijie Xu, Shuangshuang Zeng, et al.
Cancer Biomarkers (2019) Vol. 24, Iss. 4, pp. 449-459
Closed Access | Times Cited: 28
NAD metabolism in aging and cancer
John W. R. Kincaid, Nathan A. Berger
Experimental Biology and Medicine (2020) Vol. 245, Iss. 17, pp. 1594-1614
Open Access | Times Cited: 24
Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
Amandine Badie, Christian Gaiddon, Georg Mellitzer
Cancers (2022) Vol. 14, Iss. 21, pp. 5472-5472
Open Access | Times Cited: 15
Sirtuins (SIRTs) As a Novel Target in Gastric Cancer
Agata Poniewierska-Baran, Paulina Warias, Katarzyna Zgutka
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15119-15119
Open Access | Times Cited: 15
miR-15a-5p enhances the malignant phenotypes of colorectal cancer cells through the STAT3/TWIST1 and PTEN/AKT signaling pathways by targeting SIRT4
Jiaqiang Deng, Huani Wang, Yutong Liang, et al.
Cellular Signalling (2022) Vol. 101, pp. 110517-110517
Closed Access | Times Cited: 14
Oncometabolic role of mitochondrial sirtuins in glioma patients
Maria Fazal Ul Haq, Muhammad Zahid Hussain, Ishrat Mahjabeen, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281840-e0281840
Open Access | Times Cited: 8
SIRT4 prevents excitotoxicity via modulating glutamate metabolism in glioma cells
Gizem Dönmez, Merve Colak
Human & Experimental Toxicology (2020) Vol. 39, Iss. 7, pp. 938-947
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top